Price (delayed)
$1.49
Market cap
$51.77M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.73
Enterprise value
$48.72M
Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary ...
Highlights
Microbot Medical's EPS has increased by 30% YoY and by 9% QoQ
Microbot Medical's debt has plunged by 52% YoY but it has increased by 18% from the previous quarter
MBOT's quick ratio is up by 32% YoY but it is down by 30% from the previous quarter
The equity has decreased by 22% YoY and by 7% QoQ
MBOT's net income is down by 7% year-on-year and by 2.1% since the previous quarter
Key stats
What are the main financial stats of MBOT
MarketValuationsEarnings
Shares outstanding
34.74M
Market cap
$51.77M
Enterprise value
$48.72M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$11.63M
Net income
-$11.44M
EBIT
-$11.44M
EBITDA
-$11.35M
Free cash flow
-$8.85M
Per shareBalance sheetLiquidity
EPS
-$0.73
EPS diluted
-$0.73
Free cash flow per share
-$0.57
Book value per share
$0.21
Revenue per share
$0
TBVPS
$0.39
Total assets
$6.03M
Total liabilities
$2.5M
Debt
$111,000
Equity
$3.53M
Working capital
$3.36M
Debt to equity
0.03
Current ratio
2.37
Quick ratio
2.24
Net debt/EBITDA
0.27
MarginsEfficiencyDividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-175.8%
Return on equity
-234%
Return on invested capital
-356.7%
Return on capital employed
-320.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MBOT stock price
How has the Microbot Medical stock price performed over time
Intraday
-5.1%
1 week
2.05%
1 month
9.56%
1 year
18.25%
YTD
33.04%
QTD
-1.32%
Financial performance
How have Microbot Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.63M
Net income
-$11.44M
Gross margin
N/A
Net margin
N/A
MBOT financials
MBOT's operating income is down by 18% year-on-year and by 13% since the previous quarter
MBOT's net income is down by 7% year-on-year and by 2.1% since the previous quarter
Growth
What is Microbot Medical's growth rate over time
MBOT growth chart
Valuation
What is Microbot Medical stock price valuation
P/E
N/A
P/B
7.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Price to earnings (P/E)
Microbot Medical's EPS has increased by 30% YoY and by 9% QoQ
Price to book (P/B)
The stock's price to book (P/B) is 117% more than its 5-year quarterly average of 3.3 and 99% more than its last 4 quarters average of 3.6
The equity has decreased by 22% YoY and by 7% QoQ
Price to sales (P/S)
Efficiency
How efficient is Microbot Medical business performance
The ROE has contracted by 43% YoY and by 7% from the previous quarter
MBOT's return on assets is down by 40% year-on-year and by 11% since the previous quarter
The company's return on invested capital fell by 31% YoY and by 16% QoQ
Dividends
What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MBOT.
Financial health
How did Microbot Medical financials performed over time
Assets vs liabilities
The total assets is 141% higher than the total liabilities
MBOT's total liabilities has surged by 79% since the previous quarter but it is down by 35% year-on-year
The current ratio is down by 35% from the previous quarter but it is up by 13% YoY
Debt vs equity
Microbot Medical's debt is 97% less than its equity
Microbot Medical's debt has plunged by 52% YoY but it has increased by 18% from the previous quarter
Microbot Medical's debt to equity has surged by 50% QoQ but it has decreased by 40% YoY
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.